New CETSA® Publication – Quantitative target engagement of RIPK1 in human whole blood
In a recent collaboration between AbbVie Chemical Biology and Pelagoo Bioscience, CETSA® was applied to quantify direct target engagement of several inhibitors in unprocessed human whole blood. The study investigated RIPK1 as a proof-of-concept target, showcasing the high sensitivity and…